CXCR4 and breast cancer: Administration of the monoclonal antibody to CXCR4 to SCID mice was found to effectively regress lung metastasis from MDA-MB-231 xenografts, indicating the key roles of chemokines and chemokine receptors in the organ-specific metastasis of breast cancer.